Dezhan Healthcare Company Limited

000813

CNE000000VV8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
2.54 ^CNY	+2.42%		-0.78%	-22.32%

04-24	Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

May 24, 2021 at 03:42 pm

Dezhan Healthcare Company Limited at its annual general meeting of 2020 on 21 May 2021, approved Cash dividend/10 shares (A shares) (tax included) of CNY 2.10000000. Record date is 31 May 2021, Ex-date is 01 June 2021 and Payment date is 01 June 2021.

Latest news about Dezhan Healthcare Company Limited

Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-11	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Dezhan Healthcare Company Limited completed the acquisition of additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd.	23-10-15	CI
Dezhan Healthcare to Boost Stake in Deyi Pharmaceutical for 37.8 Million Yuan; Shares Slump 8%	23-09-28	MT
Dezhan Healthcare Company Limited agreed to acquire additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd. for CMY 37.8 million.	23-09-26	CI
Dezhan Healthcare Company Limited(XSEC:000813) added to S&P Global BMI Index	23-09-18	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Dezhan HealthCare Chairman Resigns	23-05-29	MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	23-05-26	CI
Equity Buyback announced on September 7, 2022 has expired with 52,913,582 shares, representing 2.33% for CNY 180.26 million.	23-05-24	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	23-04-05	CI
Dezhan HealthCare Earmarks 489 Million Yuan on Medical Health Complex Project	23-02-01	MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	23-01-03	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	22-10-11	CI
Dezhan HealthCare Settles Litigation With Former Investment Partner	22-10-04	MT
Dezhan Healthcare Company Limited commences an Equity Buyback Plan for CNY 345 million, under the authorization approved on May 26, 2022.	22-09-06	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-26	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Dezhan Healthcare Company Limited Announces Executive Appointments	21-09-01	CI

Chart Dezhan Healthcare Company Limited

Duration

Period

More charts

Company Profile

Dezhan HealthCare Co Ltd, formerly Xinjiang Tianshan Wool Tex Stock Co Ltd, is a China-based company mainly engaged in the research and development, production and sales of pharmaceuticals. The Company focuses on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, ecological water and other fields. Its subsidiaries optimize the structure of combined products, introduce production lines that meet the production needs of multiple dosage forms according to product development needs, and increase products such as injections, biopharmaceuticals, and Chinese medicine preparations. The Company mainly conducts its businesses in the China market.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DEZHAN HEALTHCARE COMPANY LIMITED	-22.32%	759M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals